Spruce Biosciences, Inc.

SPRB · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$10,669$16,387$25,615$38,753
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,847$4,566$4,961$5,453
Total Curr. Assets$14,516$20,953$30,576$44,206
Property Plant & Equip (Net)$735$803$869$934
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$62$64$204$69
Total NC Assets$797$867$1,073$1,003
Other Assets$0$0$0$0
Total Assets$15,313$21,820$31,649$45,209
Liabilities
Payables$1,386$807$1,879$1,295
Short-Term Debt$539$1,243$1,636$1,905
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7,502$6,010$12,151$12,046
Total Curr. Liab.$9,427$8,060$15,666$15,246
LT Debt$500$580$659$860
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$282
Total NC Liab.$500$580$659$1,142
Other Liabilities$0$0$0$0
Cap. Leases$0$880$950$1,019
Total Liabilities$9,927$8,640$16,325$16,388
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$4$4
Retained Earnings-$274,588-$266,376-$264,309-$250,268
AOCI$0$0$0$0
Other Equity$279,974$279,556$279,629$279,085
Total Equity$5,386$13,180$15,324$28,821
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15,313$21,820$31,649$45,209
Net Debt-$9,630-$14,564-$23,320-$35,988